Home
About DL
Company Profile
Corporate culture
Qualifications and Honors
Product Solution
Clinical Microbiological Diagnosis
Industrial Microbial Testing
User Services
News Updates
DL Information
Contact DL
MALDI‑TOF MS Search
Exhibition Activities
Festive Greetings | Dier Bio wishes you a happy Lantern Festival!
The Lantern Festival, also known as the Shangyuan Festival, Little New Year, Yuanxi, or the Lantern Fair, falls on the fifteenth day of the first lunar month each year and marks the final major traditional celebration of the Chinese New Year. It is one of the time-honored festivals celebrated in China, throughout the Chinese character cultural sphere, and among overseas Chinese communities. In June 2008, the Lantern Festival was included in the second batch of China’s National Intangible Cultural Heritage list. Dier Bio extends its warmest wishes to all employees, partners, and friends from all sectors of society who care about and support the company’s development: May your life be full and harmonious, with family reunion and every wish fulfilled! May your career flourish and your finances prosper, with opportunities coming your way at every turn! May you enjoy lasting friendships and abundant blessings, with good fortune ever present! And may your heartfelt aspirations and sincere wishes always be realized. Wishing you a joyful Lantern Festival!
19
2019
/
02
[CACLP Invitation] Deer Biotech invites you to the 16th International Exhibition on Laboratory Medicine and Blood Transfusion Instruments & Reagents!
Distinguished guests, the 16th International Exhibition on Laboratory Medicine and Blood Transfusion Instruments & Reagents (CACLP) will be grandly held from March 22 to 24, 2019, at the Nanchang Greenland International Expo Center. At that time, Dier Biotechnology will showcase a range of products at Booth A4-S92, with numerous highlights focused on the field of microbiological diagnostics. We warmly welcome your visit and guidance, and look forward to collaborating and exchanging ideas with you. Zhuhai Dier Bioengineering Co., Ltd. Dier Biotechnology [Invitation] Exhibition Information: The annual premier event in the in vitro diagnostics industry—combining professionalism, scale, and influence—the 16th International Exhibition on Laboratory Medicine and Blood Transfusion Instruments & Reagents.
12
03
[Highlights] Dier Biotech – 2019 CACLP
The highly anticipated 16th International Exhibition on Laboratory Medicine and Blood Transfusion Instruments & Reagents (CACLP) was grandly held from March 22 to 24, 2019, at the Nanchang Greenland International Expo Center, achieving complete success. Over the three-day event, more than 800 exhibitors gathered, and the exhibition drew large crowds on its opening day. At this show, Dier Biotechnology showcased automated diagnostic systems for infectious disease testing—including bacterial morphology analysis, culture, identification, and in vitro antimicrobial susceptibility testing—along with their corresponding reagents. Experts, scholars, and industry professionals from across China visited Dier Biotechnology’s booth A4‑S92 to tour, seek advice, and engage in discussions. Dier Biotechnology’s products were bestsellers.
25
Interpretation of the “Notice from the General Office of the National Health Commission on Continuously Strengthening the Management of Clinical Use of Antimicrobial Agents”
In order to thoroughly implement the Outline of the “Healthy China 2030” Plan and the National Action Plan on Controlling Bacterial Resistance (2016–2020), and to continuously strengthen the management of clinical antimicrobial use, ensure medical quality, and curb bacterial resistance, the National Health Commission has issued the “Notice on Continuously Strengthening Relevant Work in the Clinical Management of Antimicrobial Agents” (hereinafter referred to as the “Notice”).
04
Notice from the General Office of the National Health Commission on Continuously Strengthening the Management of Clinical Use of Antimicrobial Agents
To thoroughly implement the “Healthy China 2030” Planning Outline and the National Action Plan to Contain Bacterial Resistance (2016–2020), further strengthen the management of clinical antimicrobial use, ensure medical quality, and curb bacterial resistance, the following work requirements are hereby put forward.